Пиперацилин/Тазобактам Панфарма

Пиперацилин/Тазобактам Панфарма is a broad-spectrum injectable antibiotic combining piperacillin and tazobactam. Used to treat bacterial infections where resistant strains are suspected. Suitable for intravenous administration in clinical settings. Commonly prescribed for hospital-acquired infections.

Piperacillin/tazobactam is used to treat a variety of bacterial infections, including pneumonia, urinary tract infections, and intra-abdominal infections. It is often prescribed when infections may be caused by bacteria resistant to other antibiotics. The combination works by disrupting bacterial cell walls and inhibiting beta-lactamase enzymes. It is typically administered in a hospital or clinical environment.

This medication works by stopping the growth of bacteria, allowing the immune system to clear the infection more effectively. Patients may experience symptom improvement within days of starting treatment. Common effects include reduced fever, pain relief, and improved breathing in cases of respiratory infection. The full course should be completed as prescribed.

This medication should only be handled and administered by trained healthcare professionals. It is not for self-administration. Patients with known allergies to penicillin or cephalosporins should inform their healthcare provider. Proper storage and disposal of unused medication are required to prevent misuse or contamination.

Piperacillin/tazobactam may interact with certain medications, including blood thinners and other antibiotics. Alcohol consumption should be avoided during treatment. Patients should disclose all current medications to their healthcare provider. The risk of interactions is higher in patients with kidney or liver conditions.